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ABSTRACT
Protein conjugation with small ubiquitin-related modifier (SUMO) is a
post-translational modification that modulates protein interactions
and localisation. RANBP2 is a large nucleoporin endowed with
SUMO E3 ligase and SUMO-stabilising activity, and is implicated in
some cancer types. RANBP2 is part of a larger complex, consisting of
SUMO-modified RANGAP1, the GTP-hydrolysis activating factor for
the GTPase RAN. During mitosis, the RANBP2–SUMO-RANGAP1
complex localises to the mitotic spindle and to kinetochores after
microtubule attachment. Here, we address the mechanisms that
regulate this localisation and how they affect kinetochore functions.
Using proximity ligation assays, we find that nuclear transport
receptors importin-β and CRM1 play essential roles in localising the
RANBP2–SUMO-RANGAP1 complex away from, or at kinetochores,
respectively. Using newly generated inducible cell lines, we show that
overexpression of nuclear transport receptors affects the timing of
RANBP2 localisation in opposite ways. Concomitantly, kinetochore
functions are also affected, including the accumulation of SUMO-
conjugated topoisomerase-IIα and stability of kinetochore fibres.
These results delineate a novel mechanism through which nuclear
transport receptors govern the functional state of kinetochores by
regulating the timely deposition of RANBP2.
KEY WORDS: RANBP2, Importin-β, CRM1/exportin 1, Kinetochore
function, Proximity ligation assay
INTRODUCTION
Protein conjugation with SUMO (small ubiquitin-related modifier)
peptides is a post-translational modification of growing importance
in cell division (reviewed by Wan et al., 2012; Flotho and Werner,
2012; Eifler and Vertegaal, 2015). SUMO addition modifies the
interaction surfaces of proteins and can modulate their interaction
profile, localisation or function. Indeed, SUMO conjugation often
targets and ‘rewires’, and/or relocates proteins acting in rapid
responses and dynamic signalling processes.
RAN-binding protein 2 (RANBP2; also known as NUP358,
nucleoporin of 358 kDa), is the largest nucleoporin (NUP) in
nuclear pore complexes (NPCs). It is endowed with SUMO E3-type
ligase activity (Pichler et al., 2002). Overlapping with the SUMO
ligase domain is a binding domain for SUMO-conjugated proteins
(SUMO-interacting motif, SIM), which RANBP2 uses to associate
with, and stabilise, SUMO-conjugated proteins (Werner et al.,
2012). RANBP2 has a modular structure (Wu et al., 1995;
Yokoyama et al., 1995) that includes four RAN-GTPase-binding
domains (RBDs), phenyl/glycine (FG)-rich regions shared with
other NUPs, a zinc-finger region and a cyclophilin-homologous
domain.
A major RANBP2 target is RANGAP1, the GTP-hydrolysis
activating factor for the GTPase RAN. RANBP2 associates with
and stabilises SUMOylated RANGAP1 (SUMO-RANGAP1)
through the SIM domain and tethers it to NPCs (Matunis et al.,
1996, 1998; Mahajan et al., 1997), while unconjugated RANGAP1
is soluble in the cytoplasm. In turn, RANGAP1 association with
RANBP2 reinforces its SUMO E3 activity: RANBP2 and
RANGAP1 are actually viewed as components of a multimeric
SUMO ligase unit that also includes the E2 SUMO-conjugating
enzyme UBC9, known as the RRSU (RANBP2–RANGAP1-
SUMO–UBC9) complex (Werner et al., 2012).
RANBP2 and SUMO-RANGAP1 associate throughout the cell
cycle (Swaminathan et al., 2004). After nuclear envelope (NE)
breakdown and NPC disassembly, they both localise to mitotic
microtubules (MTs) and a fraction accumulates at kinetochores
(KTs) after MT attachment (Joseph et al., 2002). RANGAP1
localisation to KTs requires SUMOylation and RANBP2 function
(Joseph et al., 2004).
In addition to RANBP2–SUMO-RANGAP1, SUMO-specific
isopeptidases also reside at centromeres and KTs (Zhang et al.,
2008; Cubeñas-Potts et al., 2015) and play roles in centromere and
KT functions (Mukhopadhyay and Dasso, 2010; Cubeñas-Potts
et al., 2013). These findings suggest that cycles of SUMOylation
and deSUMOylation modulate proteins in KT-directed mitotic
processes that ultimately govern chromosome segregation (Wan
et al., 2012).
Both RANGAP1 and RANBP2 play roles in MT nucleation and
stability. RANGAP1 decreases the local RANGTP concentration at
KTs. In physiological mitosis, RANGTP activates KT-directed
nucleation of MTs (Tulu et al., 2006) that contribute to the spindle
organisation (reviewed by Cavazza and Vernos, 2015; Prosser and
Pelletier, 2017). KT-associated RANGAP1 is critical to RANGTP
turnover at KTs, and hence to modulation of KT-directed MT
nucleation and K-fibre stability (Torosantucci et al., 2008). RANBP2
also plays a role in MT nucleation and stabilisation. That role is
critical in the presence of specific mutations found in certain cancers
(e.g. BRAF mutations). Remarkably, RANBP2 confers a
‘vulnerability’ to those cancers by rendering them sensitive to the
MT-targeting drug vinorelbine (Vecchione et al., 2016).
The RRSU complex also facilitates the disassembly of export
complexes (Ritterhoff et al., 2016) formed by the nuclear export
vector exportin-1 (CRM1; chromosome region maintenance 1),Received 26 September 2016; Accepted 5 June 2017
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cargo proteins carrying nuclear export signals (NES), and
RANGTP, which stabilises the complex. In nuclear export,
RANGAP1 activates RANGTP hydrolysis at the NPC and
initiates export complex disassembly and release of the NES
cargo. RRSU complexes at MT-attached KTs (Joseph et al., 2004)
may similarly facilitate the release of KT proteins harbouring NES
signals. Understanding how the RRSU complex is itself regulated in
space and time during mitosis is therefore a relevant question.
Both RANBP2 and RANGAP1 interact with nuclear transport
receptors during nuclear transport cycles. RANBP2 interacts via
FG-rich domains with importin-β, the main vector of protein import
in interphase nuclei. RANBP2 is the most cytoplasmic NUP, and
interacts with importin-β in the initial steps of the import cycle, i.e.
when import complexes assembled in the cytoplasm dock to the
NPC to traverse it (Bednenko et al., 2003; Christie et al., 2016).
After NE breakdown, importin-β associates with mitotic MTs
(Ciciarello et al., 2004) and interacts with spindle-associated and
MT-regulatory factors. The binding to importin-β keeps these
factors inactive (Ciciarello et al., 2007; Clarke and Zhang, 2008;
Kalab and Heald, 2008), hence keeping mitotic progression on
schedule by preventing the premature onset of mitotic events;
importin-β acts therefore as a global negative regulator of mitosis
(reviewed by Forbes et al., 2015). When overexpressed, importin-β
causes an array of mitotic abnormalities (Nachury et al., 2001;
Ciciarello et al., 2004; Kaláb et al., 2006), including the inhibition
of RANGAP1 localisation to KTs (Roscioli et al., 2012).
RANBP2 and RANGAP1 also interact with CRM1, the export
vector for proteins out of the nucleus. The former uses a zinc finger-
containing domain (Singh et al., 1999). The latter contains several
NES motifs and requires CRM1 for its cytoplasmic localisation
(Cha et al., 2015). During mitosis, CRM1 fractions localise at
centrosomes (Forgues et al., 2003; Budhu and Wang, 2005), MTs
and KTs (Arnaoutov et al., 2005; Zuccolo et al., 2007; Wu et al.,
2013). The KT-associated CRM1 fraction is required to localise
several proteins therein, including SUMO-RANGAP1 and
RANBP2 (Arnaoutov et al., 2005).
These findings implicate nuclear transport receptors in the mitotic
localisation of the RRSU complex. The underlying mechanisms,
and the functional consequences for mitotic progression, remain
unclear, however. If nuclear transport receptors contribute to
determine the RRSU complex localisation, they should also
determine the sites of RANBP2-dependent SUMOylation of
mitotic proteins and influence processes that depend upon it.
To address these questions, we have visualised the interactions
between transport factors and the RANBP2–SUMO-RANGAP1
complex during mitosis. Using proximity ligation assays (PLAs)
and inducible cell lines to modulate the expression of each transport
factor, we find that importin-β and CRM1 have opposite functions
in a finely tuned mechanism that regulates the RANBP2-
RANGAP1 complex at mitotic MTs and KTs, respectively.
Through this mechanism, importin-β and CRM1 influence mitotic
processes that require RANBP2 activity, including the KT
localisation of SUMO-conjugated topoisomerase II alpha
(TOP2A), and the stability of KT microtubules, or K-fibres.
RESULTS
RANBP2 interactions with nuclear transport receptors are
spatially and temporally regulated before and after MT
attachment to chromosomes
Most RAN network components and effectors are shuttling proteins
and establish dynamic interactions that have been difficult to depict
in whole cells without resorting to expressing exogenous tagged
proteins. The PLA technique visualises interactions between native
proteins located in close proximity (within 30 nm) in situ (see
Materials and Methods). In human mitotic cells, it was used to
visualise interacting members of the chromosomal passenger
complex (Vuoriluoto et al., 2011).
We took advantage of PLA technology to analyse RRSU
interactions in mitotic HeLa cells. In pilot experiments, we
selected known interacting pairs, i.e. RANBP2-RANGAP1 and
RAN-CRM1. PLA signals for both combinations accumulated at
the nuclear rim, and, to a lesser extent in the cytoplasm for
RANBP2-RANGAP1 and in the nucleus for RAN-CRM1 (Fig. S1),
as expected from the localisation of single proteins. No signal was
observed in PLA reactions using antibodies to RANBP2 and a non-
expressed protein, i.e. GFP (data not shown).
We then investigated PLA products formed by RANBP2 and
nuclear transport receptors. In interphase, RANBP2 PLA products
with both importin-β (Fig. 1A) and CRM1 (Fig. 1C) were restricted
to the NE region, visualised by lamin B1, consistent with the
resident nature of RANBP2 at NPCs.
To follow the redistribution of RANBP2–importin-β PLA
products from interphase to mitosis, we stained cells for lamin
B1, MTs (α-tubulin) and KTs (CREST antibody) (Fig. S2A). This
showed a progressive relocalisation of RANBP2–importin-β PLA
signals from the interphase NE rim to MTs: as the NE deforms
under centrosomal pushing, and eventually breaks down, PLA
products are released in the cytoplasm and gradually associate with
the growing mitotic MTs. In prometaphase, abundant PLA signals
accumulate at MTs. Most signals can be inscribed within the
profiles of the forming half spindles and excluded from
chromosomes (Fig. 1B, top row). As MT-KT attachments are
established and chromosomes become bioriented, PLA signals
decrease. In anaphase, fewer PLA signals are visualised, mostly
associated with interpolar rather than KT-bound MTs (stage-
specific panels are shown in Fig. S2A).
We next examined the RANBP2-CRM1 combination. Low-
abundance PLA products were detected at MTs in early mitosis,
which increased in metaphase. At that stage, PLA signals began to
concentrate at the outer CREST-stained KTs and remained
associated with KTs during segregation in anaphase (detailed
mitotic progression in Fig. S2B). In telophase, when the spindle
disassembled, PLA products for both the RANBP2–importin-β and
RANBP2-CRM1 combinations relocalised around chromatin,
indicating that the NE was reforming. The PLA patterns are
consistent with the immunofluorescence (IF) localisation of
individual components (Joseph et al., 2002, 2004; Ciciarello
et al., 2004; Arnaoutov et al., 2005; Wu et al., 2013). Thus, the
PLA approach visualises interacting, or closely associated,
endogenous RANBP2 and nuclear transport receptors, and can
depict variations in these interactions at the intracellular site at
which they occur.
Although PLA cannot measure the absolute amount of interacting
proteins within cells, as it entails an amplification step, the PLA
patterns suggested that RANBP2 interactions varied before and after
MT attachment to chromosomes. We compared quantitative
estimates of PLA signals either manually or automatically
(counting every single PLA signal as an object; details in
Materials and Methods), with consistent results; henceforth the
automatic mode was used unless specified otherwise. We counted
PLA signals either throughout the cells, or at MTs, or in the
chromosome-KT area, then grouped the cells in discrete classes
according to their PLA signal content, and compared the profile of
prometaphases and metaphases in unperturbed cell populations. In
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RANBP2–importin-β PLA reactions, we counted significantly
fewer signals in metaphases compared with prometaphases, both
at spindle MTs (Fig. 1B) and in whole cells (data not shown); thus,
metaphase marked a real quantitative decrease of RANBP2
interaction with importin-β, rather than delocalisation from MTs.
RANBP2 PLA products with CRM1 showed the opposite trend,
with a significant increase from prometaphase to metaphase in
whole cells, which coincided with the appearance of PLA products
in the chromosome KT region in metaphase (Fig. 1D). In addition,
we observed a clear shift in the modal class of abundance of
RANBP2-containing PLA products with each one of nuclear
transport receptors before and after metaphase alignment.
Fig. 1. RANBP2-CRM1 and RANBP2–importin-β
PLA products are spatially and temporally
regulated in mitosis. (A) In interphase, RANBP2
PLA reactions with importin (Imp)-β are visible at the
NE (lamin staining). (B) RANBP2–importin-β PLA
signals during mitotic progression. PLA products
localise mainly to MTs (delimited by the green profile;
MT and chromosome staining are shown below). The
graph quantifies RANBP2–importin-β PLA products
associated with MTs in mitotic stages: prometaphase
(upper panel) and metaphase (lower panel) cells are
grouped in discrete classes according to their content
of MT-associated PLA products (inset key); the
histograms represent the frequency of cells in each
class. Red arrows indicate modal classes. The
decrease in metaphase versus prometaphase cells
was highly significant (P<0.0001, χ2 test); n=180
prometaphases and 320 metaphases (nine
experiments). The IF panels at the bottom show the
detail of RANBP2–importin-β PLA products along
MTs in prometaphase and metaphase (insets, 2×
zoom). (C) Interphase RANBP2-CRM1 PLA products
at the NE (lamin staining). (D) RANBP2-CRM1 PLA
signals localise at MTs and, after metaphase, in part
also at chromosomes (delimited by the blue profile).
The histograms represent the frequency of
prometaphase versus metaphase cells grouped in
classes of abundance of RANBP2-CRM1 PLA
products counted in the chromosome KT area. The IF
panels at the bottom show that RANBP2-CRM1 PLA
products become KT-associated in metaphase
(insets, 2× zoom), with a highly significant increase
compared with prometaphase (P<0.0005, χ2 test);
n=140 prometaphases and 540 metaphases, nine
experiments. Counting the overall number of PLA
products in whole cells revealed the same trend and
level of statistical significance shown in graphs B and
D. Scale bars: 5 μm. Extended images for both pairs
during mitotic progression are shown in Fig. S2.
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These results suggest that RANBP2 takes part in two distinct
associations that include importin-β and CRM1, respectively. These
variations suggest that a RANBP2 fraction ‘switches partners’ from
prometaphase, when it forms abundant interactions with importin-β
along the spindle MTs, to metaphase, when its association with
MTs decreases and PLA signals with CRM1 increase at the level of
MT-attached KTs.
To control the PLA specificity, we silenced RANBP2, which
should prevent the formation of PLA products. RANBP2-specific
siRNAs effectively downregulated RANBP2 abundance compared
with controls treated with control siRNAs (GL2, targeting the
luciferase gene) (Fig. S3A). As a read-out, SUMOylated RANGAP1
decreased in RANBP2-silenced cells compared with controls (Fig.
S3A), which coincided with the absence of RANGAP1 from
metaphase KTs in IF images (Fig. S3B). RANBP2-depleted cultures
showed lengthenedmitotic duration, paralleled by the appearance of
multipolar spindles and misaligned chromosomes (Fig. S3C), as
expected (Salina et al., 2003; Joseph et al., 2004; Hashizume et al.,
2013). In RANBP2-silenced cultures we found no, or very few, PLA
signals, for both importin-β–RANBP2 (Fig. S3D) and CRM1-
RANBP2 (Fig. S3E) at MTs, KTs and in whole cells. Although
importin-β abundance was reported to decrease in RANBP2-
interfered cells in other experiments (Hashizume et al., 2013),
neither importin-β nor CRM1 abundance displayed significant
variations under the conditions used in this study (Fig. S3A); thus
downregulation of PLA products truly reflects the loss of RANBP2
protein in silenced cultures, indicating that the PLA technique
depicts genuine RANBP2 interactions in mitotic cells.
RANBP2 and RANGAP1 are engaged as a unit in regulated
interactions with nuclear transport receptors
Given that SUMO-RANGAP1 associates with RANBP2
throughout the cell cycle (Swaminathan et al., 2004), the
localisation of PLA products between RANBP2 and each nuclear
transport receptor should parallel that of RANGAP1, or at least a
fraction thereof. To test this, we repeated the PLA reactions with
nuclear transport receptors using RANGAP1. As with RANBP2,
RANGAP1 also formed abundant PLA products with importin-β at
the MT level in prometaphase, which decreased in metaphase
(Fig. S4A). This suggests that a RANGAP1 fraction associates,
directly or via RANBP2, with importin-β in early mitosis and
detaches from it when MTs attach to KTs.
Conversely, RANGAP1-CRM1 PLA products increased from
prometaphase to metaphase, at which stage they became visible in
the chromosome area (Fig. S4B). Interestingly, RANGAP1-CRM1
PLA products were barely detectable when using a CRM1 antibody
targeting the CRM1 N-terminal region, which contains the
RANGTP-binding domain; the N-terminal CRM1 antibody also
failed to detect CRM1 at KTs (Fig. S4C). These observations
suggest that CRM1 requires a free RAN-binding domain in order to
localise at KTs and recruit RANGAP1 therein; once anchored, the
domain is probably not available to the antibody. Direct
examination of RANBP2-RANGAP1 PLA products finally
revealed signals along MTs in prometaphase, with a fraction
accumulating at KTs in metaphase (Fig. S4D).
In summary, both RANBP2 and RANGAP1 establish parallel
interactions with importin-β at MTs, which decrease at metaphase,
and with CRM1 at MTs and at metaphase KTs. This suggests that
they engage as a unit in complementary interactions with nuclear
transport receptors with mitotic stage-specific patterns. The partner
switch becomes evident after chromosome alignment rather than in
prometaphase, when MT-KT interactions are first established. We
conclude, therefore, that the event of biorientation, rather than
MT-KT contact per se, marks a key step in the ‘switch partners’
model for the RANBP2-RANGAP1 complex.
CRM1 post-transcriptional silencing or functional inhibition
downregulate RANBP2-containing PLA products at
kinetochores
To assess whether the KT-associated CRM1 fraction plays an active
role in the RANBP2 metaphase switch, we inactivated CRM1 in
different ways to see how that would affect PLA patterns during
mitotic progression. We first silenced CRM1 post-transcriptionally
using siRNAs (Fig. 2A). That yielded multipolar mitoses and
significant chromosome misalignment and mis-segregation
(Fig. 2B), as expected (Arnaoutov et al., 2005). Under these
conditions, RANBP2-CRM1 PLA products were severely
downregulated, and a substantial proportion of cells displayed no,
or rare, PLA signals both in the chromosome KT region (Fig. 2C)
and throughout the cell. Thus, although RNA interference protocols
may not completely deplete the targeted proteins, and the PLA
technique includes an amplification step that can amplify products
generated by the residual protein, the CRM1-silencing experiments
(Fig. 2A-C) indicate that the stage-specific variations previously
depicted using the PLA approach were genuine.
Because the RNA interference protocol took 48–72 h to achieve
effective CRM1 silencing, we sought to rule out possible indirect
effects caused by long-term alterations in interphase nuclear export.
We therefore repeated the PLA assays after short-term treatment
with leptomycin B (LMB) to inhibit CRM1 function. CRM1
inhibition was demonstrated by the nuclear retention of RANBP1, a
characterised NES-containing export cargo, in interphase (Fig. 2D),
and induction of mitotic abnormalities similar to those observed
after CRM1 silencing (Fig. 2E). We found that a 2 h pulse of LMB
was sufficient to inhibit the formation of CRM1-RANBP2 PLA
products in mitotic cells (Fig. 2F). Interestingly, LMB did not affect
the formation of RANBP2-RANGAP1 PLA products, but
prevented their accumulation at KTs (Fig. S4E). Thus LMB
blocks the ‘switch partners’ step occurring in normal mitotic cells
and prevents the localisation of RANBP2-CRM1 PLA products to
metaphase KTs.
In summary, loss-of-function experiments validate the ‘switch
partners’ model depicted in PLA assays: they substantiate the
conclusion that both RANBP2 and RANGAP1 interact with nuclear
transport receptors during mitosis, and highlight a specific shift
coinciding with chromosome biorientation: at this time, their
interaction with importin-β decreases along the spindle MTs and the
complexes with CRM1 increase and accumulate at KTs.
Induction of importin-β overexpression alters RANBP2
interactions and localisation in mitotic cells
At this point we asked whether unbalancing transport factors would
perturb the RRSU complex mitotic localisation. Previous studies
examined the consequences of importin-β overexpression in mitosis
in transient assays, consistently reporting multipolar spindles and
chromosomemis-segregation (Nachury et al., 2001; Ciciarello et al.,
2004; Kaláb et al., 2006), as well as inhibition of SUMO-
RANGAP1 accumulation at KTs (Roscioli et al., 2012). If RRSU
moves as a complex, then importin-β overexpression should also
influence the localisation of RANBP2 and impact on mitotic
processes that depend upon it. To verify this we needed to eliminate
the variability associated with transient expression.We established a
HeLa cell line with stably integrated EGFP-tagged importin-β under
the control of a doxycycline (dox)-inducible promoter (seeMaterials
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and Methods). In time-lapse microscopy, all cells expressed
importin-β–EGFP with similar intensity starting 3–4 h after dox
addition. Overall, importin-β abundance increased by about 1.8-fold
6 h after dox induction, and 2.5-fold after 24 h (Fig. 3A), and
overexpressed importin-β–EGFP reproduced the localisation of the
endogenous protein at the spindle MTs (Fig. 3B). In time-lapse
analysis, mitotic cells underwent lengthened prometaphase and
metaphase duration early after importin-β induction (6 h), associated
with severe alterations in the spindle bipolarity and/or function; over
time (24 h), a significant proportion died during mitosis or in the
next interphase (Fig. 3C). Consistent with this, fixed IF-stained
cultures showed significant chromosome misalignment and mis-
segregation (Fig. 3D). Thus, importin-β overexpression, albeit mild,
hinders spindle organisation and function.
We next examined RANBP2 interactions with transport receptors
in the importin-β-inducible cell line. We found significantly
Fig. 2. CRM1 silencing or functional inhibition abolish RANBP2-containing PLA products. (A) CRM1 silencing substantially reduces CRM1 protein levels.
(B) Induction of mitotic abnormalities in CRM1-silenced cultures compared with GL2-interfered controls (***P<0.0001, χ2 test); n≥3000 mitotic cells, three
experiments. The IF panels exemplify frequent defects: multipolar spindles (top), misaligned (middle) and mis-segregating chromosomes (bottom).
(C) Histograms represent the frequency of mitotic cells grouped in classes of abundance of KT-associated RANBP2-CRM1 PLA products in CRM1-silenced
and control (GL2) cells (P<0.025, χ2 test in two experiments, n=50 cells per condition). (D) LMB abolishes nuclear export of RANBP1 in interphase. (E) Induction
of mitotic abnormalities in LMB-treated cultures compared with controls (***P<0.0001, χ2 test); n≥3400 cells, two experiments. (F) Distribution of mitotic cells
in classes of abundance of RANBP2-CRM1 PLA products at KTs, in LMB-treated and control cultures (P<0.0001, χ2 test); n=60 cells per condition, two
experiments. Red arrows indicate modal classes. Scale bars: 5 μm (except in panel D, where scale bar denotes 20 μm).
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increased RANBP2–importin-β PLA signals compared with
controls. These signals mostly localised at the spindle MTs and,
importantly, remained abundant in metaphase (Fig. 3E), when they
normally decrease in non-induced cells. Concomitantly, RANBP2-
CRM1 PLA products were downregulated in whole cells, and
hardly any signal was seen at metaphase chromosomes, in induced
compared with non-induced cultures (Fig. 3F). Thus, increased
importin-β levels retain RANBP2 at MTs, and prevent the shift in
the balance between MT-bound and KT-bound RRSU complex that
takes place in metaphase.
CRM1 overexpression alters the timing of RANBP2-
dependent interactions in mitosis
We asked whether inducing elevated CRM1 levels would
symmetrically affect RANBP2 mitotic interactions. We generated
a dox-inducible CRM1-EGFP HeLa cell line using the same vector
Fig. 3. Importin-β retains RANBP2 at MTs and decreases its association with CRM1. (A) Cell extracts were probed with importin-β antibody after dox
induction. The upper importin-β band corresponds to dox-induced EGFP chimaera, the lower band is the endogenous protein. (B) Dox-induced importin-β-EGFP
reproduces the endogenous protein localisation at spindle MTs. (C) Time-lapse imaging data, showing the evolution of mitotic abnormalities recorded 6 or 24 h
after importin-β induction (*P<0.01 compared with controls, χ2 test); n≥115 mitoses per time point, three experiments. (D) The IF panels exemplify mitotic
abnormalities in fixed dox-induced cell samples (multipolar mitosis, misaligned metaphase chromosome, lagging chromosome in telophase), quantified in the
histograms (*P<0.01, **P<0.0005 compared with controls, χ2 test); n≥500mitotic cells, two experiments. (E) Histograms represent the distribution of metaphases
according to their abundance of importin-β–RANBP2 PLA signals in the MT area (blue spindles), showing a highly significant increase in importin-β-induced
compared with control cells (P<0.0001, χ2 test); n≥128 cells per condition, three experiments. (F) Histograms represent the distribution of metaphases according
to their content of CRM1-RANBP2 PLA signals localising at KTs (blue), showing a highly significant decrease in importin-β-induced compared with control
metaphases (P<0.005, χ2 test); n=215 metaphases per condition, four experiments. Examples are shown in the IF panels. Scale bars, 5 μm.
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as for importin-β (see Materials and Methods). CRM1-EGFP
expression was detected by time-lapse microscopy about 3–4 h after
dox administration in stable cell lines. Dox induction yielded a mild
but reproducible increase in CRM1 expression (about 1.4-fold after
6 h, and 2-fold after 24 h) (Fig. 4A), and overexpressed CRM1
reproduced the localisation of the endogenous protein at the spindle,
with a fraction at KTs in metaphase (Fig. 4B).
Time-lapse recording of CRM1-induced cells showed significant
prometaphase and metaphase delay, with a statistically significant
fraction of recorded mitoses developing micronucleated and
multinucleated phenotypes after 24 h of recording (Fig. 4C).
Consistent with the micro-/multi-nucleation phenotypes recorded
in live cells, IF analysis of fixed cells depicted misaligned
chromosomes in metaphase, as well as abnormal anaphase and
Fig. 4. CRM1 induction anticipates RANBP2 recruitment to KTs and decreases it at MTs. (A) CRM1-EGFP induction by dox. (B) Dox-induced CRM1-EGFP
reproduces the endogenous CRM1 localisation. (C) CRM1 induces mitotic abnormalities in time-lapse assays; the histograms represent the frequency of
phenotypes recorded 6 or 24 h after CRM1 induction (*P<0.05, χ2 test); n=130 cells per sample, two experiments. (D) Mitotic abnormalities in fixed IF-stained
CRM1-induced cultures: left, metaphase misaligned chromosome; right, failed chromosome segregation in telophase (2× zoom). Abnormalities (quantified in the
histograms) increase significantly in CRM1-induced versus control cultures (*P<0.025 and **P<0.001, χ2 test); n=300mitotic cells, two experiments. (E) Importin-
β–RANBP2 PLA products at MTs (exemplified in the IF panels) in CRM1-induced and control cultures; histograms represent the distribution of metaphases
in classes of PLA abundance, and indicate a significant decrease after CRM1 induction (P<0.01, χ2 test); n=40 metaphases per condition, three experiments.
(F) RANBP2-CRM1 PLA signals at KTs significantly increase in CRM1-induced versus non-induced prometaphases. Histograms represent the distribution
of prometaphases according to their content of RANBP2-CRM1 PLA products at KTs (P<0.05, χ2 test); n=40 prometaphases per condition, two experiments.
(G) Distribution of metaphase cells according to their content of RANBP2-CRM1 PLA products at KTs: no significant variation (χ2 test) was observed (45 analysed
metaphases per condition, two experiments). Scale bars: 5 μm.
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telophase figures with chromosomes that failed to segregate
(Fig. 4D).
We found that mitotic RANBP2–importin-β PLA products were
significantly reduced in CRM1-induced cultures (Fig. 4E), while in
parallel cultures, RANBP2-CRM1 products increased in
prometaphase compared with non-induced controls (Fig. 4F). In
physiological mitoses, RANBP2-CRM1 PLA products reach
greatest abundance in metaphase and CRM1 induction did not
increase their abundance any further (Fig. 4G). Thus, increased
abundance of CRM1 impaired the formation of RANBP2–
importin-β PLA products and caused a premature RANBP2
recruitment to prometaphase KTs. Concomitant with this, cells
develop severe segregation abnormalities that remain mostly
uncorrected, thus originating micronucleated cells.
MTs are essential to RANBP2-RANGAP1 localisation in
mitotic cells
Previous assays showed that RANBP2 co-immunoprecipitated with
importin-β, with or without MTs (Roscioli et al., 2012), suggesting
that MTs are dispensable for their interaction to occur, at least in
mitotic cell extracts. To assess whether MTs played any role in
supporting RANBP2 interactions in intact cells, we pre-
synchronised cells by thymidine arrest and release, and when they
reached the G2-M transition, we applied NOC to prevent mitotic
MT assembly. Controls were pre-synchronised and left untreated
after the block release.
We compared RANBP2–importin-β PLA patterns in NOC-
arrested and untreated prometaphases. As a standard we analysed
BubR1, a spindle checkpoint component that remains associated
with unattached KTs. The results show sparse importin-β–RANBP2
PLA signals throughout mitotic-arrested cells in the NOC samples.
The overall abundance of PLA signals, however, did not change in
NOC-treated versus untreated cultures (Fig. 5A, left panel),
indicating that MTs were not essential for importin-β–RANBP2
PLA product formation.
RANBP2-CRM1 PLA products also showed disperse patterns.
We found that manual counting of PLA spots relative to the KTs in
single planes was more accurate than automated counting in cells
devoid of MTs with widespread chromosomes. After manual
counting, the amount of RANBP2-CRM1 PLA signals was again
comparable in NOC-treated versus untreated cells (Fig. 5A, right
panel). However, different from BubR1 signals that associated with
CREST-stained KTs in all planes (Fig. 5B, left), only some of the
CRM1-RANBP2 PLA signals genuinely localised at KTs, while a
large fraction laid in different planes from KTs (Fig. 5B, right).
Thus, NOC decreased the association of CRM1-RANBP2 PLA
signals with KTs (Fig. 5C), but did not modify their abundance. In
summary, MTs are not required as an assembly platform for
RANBP2 PLA product formation with nuclear transport receptors,
but they are necessary for their localisation.
Overexpression of CRM1 or importin-β affects SUMOylation
of topoisomerase-IIα in opposite ways
The results thus far delineate a dynamic scenario in which the
mitotic localisation of RANBP2 depends on the antagonistic
activities of importin-β, which retains it at the spindle MTs,
versus CRM1, which drives its transfer to KTs after MT attachment.
To understand whether this RANBP2 switch might affect KT
function, we decided to assess potential RANBP2 SUMOylation
substrates after induction of either importin-β or CRM1.
TOP2A plays an important role in decatenation of chromatids to
enable segregation. TOP2A localises to chromosomes in early
mitosis: in Fig. 6A, TOP2A (leftmost panel) is distributed along the
entire chromosome length in prometaphase (upper row) and
gradually concentrates at KTs in metaphase (Fig. 6A, lower row)
to act in decatenation of sister centromeres. Cells in which this is
prevented form chromatin bridges that cannot be resolved in
anaphase. These defects can give rise to aneuploid cells (reviewed
by Chen et al., 2015). In physiological mitosis, a fraction of TOP2A
is SUMOylated (Azuma et al., 2003), and impaired SUMOylation
affects the centromere decatenation function of TOP2A
(Dawlaty et al., 2008). Both PIAS-gamma (Ryu et al., 2010)
and RANBP2 (Dawlaty et al., 2008) are implicated in TOP2A
SUMO conjugation: indeed, TOP2A fails to accumulate at inner
centromeres in animal models that express lowered RANBP2 levels
(Dawlaty et al., 2008).
We wondered whether SUMO conjugation of TOP2A, besides
being affected by RANBP2 abundance, is also affected by
RANBP2 localisation. To investigate this, we adapted the PLA
protocol to detect intramolecular reactions between TOP2A and
SUMO-2/3 peptides: this protocol enabled us to visualise SUMO-
TOP2A PLA products (representative prometaphase and metaphase
PLA patterns are shown in Fig. 6B). By measuring the fraction of
SUMO-TOP2A PLA localised at KTs (visualised by CREST) over
the entire pool of SUMO-TOP2A PLA throughout the cell (plotted
in the graph), it was evident that SUMOylated TOP2A concentrates
at KTs in metaphase.
It was interesting at this point to establish whether disrupting the
importin-β- and CRM1-dependent system of RANBP2 localisation
affected the spatial pattern of SUMO-TOP2A. We first examined
CRM1-overexpressing cultures. Because CRM1 overexpression
anticipates the formation of RANBP2-CRM1 complexes at
prometaphase KTs (see Fig. 4), we focused our analysis on
scoring SUMO-TOP2A intramolecular PLA signals in
prometaphase figures that showed clearly identifiable isolated
KTs, hence MT unattached. We found that CRM1-induced cultures
displayed significant SUMO-TOP2A accumulation at MT-
unattached KTs compared with non-induced controls (Fig. 6C).
We then examined the importin-β-induced cell line, in which the
accumulation of RANBP2-CRM1 products at metaphase KTs is
impaired (see Fig. 3F). We found that the presence of SUMO-
TOP2A signals was also significantly reduced at metaphase KTs
in this cell line (Fig. 6D). In summary, therefore, conditions
that prevent the RANBP2 ‘switch partners’ model yield a
correspondingly altered timing of SUMO-TOP2A localisation at
KTs during mitotic progression.
CRM1 and importin-β overexpression affect K-fibre stability
Several studies have implicated both importin-β and CRM1 in MT
dynamic activity and stability (reviewed by Dasso, 2006; Ciciarello
et al., 2007; Kalab and Heald, 2008; Forbes et al., 2015). Based on
the data obtained thus far, we wondered whether these effects
attributed to nuclear transport factors might involve RANBP2. To
address that question, we decided to analyse cold-induced MT
depolymerisation, which is used as an informative assay to measure
MT stability. After 20 min on ice, most control metaphases
displayed partially polymerised MTs and K-fibres forming
disorganised spindles (Fig. 7A, left panel). In the importin-β-
induced cell line, most mitotic cells showed only short residual
MT fragments (Fig. 7Bb); MT destabilisation was associated
with a lack of RANBP2 localisation at KTs (Fig. 7Ba,d). We next
analysed MTs in the CRM1 cell line. After 20 min of cold
incubation, most mitotic cells retained partially polymerised MTs,
with or without CRM1 induction. When the incubation was
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prolonged to 35 min to induce extensive MT depolymerisation,
most non-induced cells lacked resistant K-fibres and displayed
short MT fragments or tubulin spots over a diffuse background
(Fig. 7D, left column). CRM1 induction resulted in more extensive
protection from cold depolymerisation and persistence of K-fibres
(Fig. 7Eb), associated with RANBP2 accumulation to KTs
(Fig. 7Ed).
In summary, importin-β and CRM1 affect the sensitivity of K-
fibres to cold-induced depolymerisation in opposite ways, and their
ultimate effect over K-fibre stability correlates with their ability to
induce the presence or absence of RANBP2 from KTs.
DISCUSSION
RAN GTPase network members, nuclear transport receptors and
components of the NPC – through which transport is operated – are
now well known to play regulatory roles in mitosis when
nucleocytoplasmic transport ceases. They regulate MT nucleation,
dynamics and interactions with KTs, largely via physical
association with mitotic structures (centrosomes, spindle poles,
MTs and KTs), and ultimately contribute to orchestrating
chromosome segregation.
Here, we focus on RANBP2, a NUPwith well-established mitotic
roles (Salina et al., 2003; Joseph et al., 2004; Hashizume et al.,
Fig. 5. NOC disrupts the localisation
but not the formation of RANBP2-
containing PLA products.
(A) Intracellular abundance of
RANBP2–importin-β (left) and
RANBP2-CRM1 (right) PLA products
in NOC-arrested and control
prometaphases: no statistical
difference was observed for either
interaction in whole cells, with or
without MTs. (B) Co-localisation
analysis of RANBP2-CRM1 PLA
products and KTs in single planes in
NOC-treated cultures. α-tubulin
(green) is diffuse, indicating that NOC
treatment was effective. Individual
planes are shown below the MIP fields.
BubR1 signals (left column) co-localise
with CREST-stained KTs in all planes
(1, 7 and 15 are shown as examples).
In the right-hand column, the MIP field
shows RANBP2-CRM1 PLA products
(red) spread throughout the cell outside
KTs (CREST). In single planes of the
apparent PLA-CREST associations
seen in the MIP image, only some are
genuine (stack 3 shows an example of
genuine localisation on the outer KT,
framed in theMIP field as in a, enlarged
in a′); other PLA signals, although
apparently overlapping with CREST, in
fact do not associate with KTs in
individual planes, as the framed
example in c in the MIP field: the c’
zoom shows the KT at stack 10,
whereas the PLA spot lies at stack 13.
This dissociation was not seen in cells
with unperturbed MTs. a′, b′ and c′, 8×
enlargements of a, b and c. Scale bar:
5 μm. (C) The histograms show a
dramatic decrease of prometaphases
with localised RANBP2-CRM1 PLA
products at KTs in NOC-treated
cultures (P<0.0001, χ2 test); n=65
cells, two experiments.
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Fig. 6. CRM1 and importin-β affect SUMO-TOP2A accumulation at KTs. (A) In physiological mitosis, TOP2A co-localises with chromosomes in prometaphase
(upper row) and concentrates at CREST-stained KTs in metaphase (lower row). (B) Examples of SUMO-TOP2A intramolecular PLA patterns in prometaphase
(upper) and metaphase (lower) cells, showing that SUMOylated TOP2A concentrates at KTs in metaphase. In the scatter plot, each point shows the ratio of KT-
associated to total SUMO-TOP2Ameasured in single cells;P<0.0001, unpaired t-test (n=22 prometaphases and 24metaphases, two independent experiments).
(C) In CRM1-overexpressing cells, SUMO-TOP2A localises at unattached KTs in prometaphase (insets, 3× zoom). Histograms represent the frequency of
individual unattached KTs that accumulate (red) or are devoid (grey) of SUMO-TOP2A PLA signals, with a significant increase in CRM1-overexpressing cells
(**P<0.005, χ2 test); PLA signals were scored at 90 unattached KTs per sample, two experiments. (D) Decreased accumulation of SUMO-TOP2A at metaphase
KTs in importin-β-induced cells. The graphs show the distribution of metaphase cells in classes of abundance of SUMO-TOP2A PLA products at KTs: importin-β-
overexpressing cultures display a significant decrease compared with controls (P<0.0001, χ2 test); n=40 scored metaphases per condition, two experiments.
Scale bars: 5 μm.
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Fig. 7. CRM1 and importin-β affect MT stability. (A) Examples of MT depolymerisation phenotypes observed after 20 min incubation on ice. (B) Example
MT patterns in control and importin-β-overexpressing cells (fewer cold-resistant MTs, concomitant with decreased RANBP2 localisation at metaphase KTs).
(C) Histograms represent the frequency of MT phenotypes after cold incubation and show a significant shift towards severe MT depolymerisation phenotypes
in importin-β versus control cultures (***P<0.0001, Fisher’s exact test); n=240 cells per sample, five experiments. (D) Typical MT depolymerisation
phenotypes after 35 min incubation on ice. (E) CRM1-overexpressing cells show more resistant K-fibres juxtaposed to RANBP2 at prometaphase KTs
compared with controls. (F) Quantification of MT phenotypes in CRM1-induced, with predominant resistant K-fibres, versus control cultures (***P<0.0001,
Fisher’s exact test); n=220 cells per group, three experiments. Scale bars: 5 μm.
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2013; Vecchione et al., 2016). In interphase transport, the interplay
between RANBP2 and nuclear transport receptors is crucial for the
correct distribution of protein cargos within cells. Here, we show
that the spatiotemporal pattern of RANBP2 in mitosis depends on
interactions with importin-β and CRM1, and impacts on relevant
processes in mitotic progression.
The PLA approach developed here provides a valuable tool to
investigate these interactions in space and time. We found that
RANBP2 PLA products with either importin-β, or with CRM1,
exhibit spatially and temporally regulated, mutually dependent
patterns that have an inverse trend before and after chromosome
biorientation. RANBP2–importin-β PLA products are abundant in
prometaphase and localise at MTs, and then are downregulated from
metaphase onwards. Conversely, RANBP2-CRM1 PLA signals
increase in metaphase, when a fraction becomes visible at KTs,
which remain KT-associated during segregation (Fig. 8). Our PLA
studies also show that RANBP2 interactions trace the RRSU
complex, because similar, parallel changes were observed when
testing RANGAP1 instead of RANBP2 in PLA reactions. The
variations detected in this study suggest an active role for importin-β
in retaining the RRSU complex along MTs before chromosome
biorientation, and for CRM1 in recruiting a fraction of the complex
once KTs become bioriented.
How may these interactions form and vary during mitotic
progression? In structural studies, importin-β interacts with
RANBP2 via a NUP-binding domain in the N-terminal region,
and FG-rich regions in RANBP2 (reviewed by Bednenko et al.,
2003; Christie et al., 2016). CRM1 – together with RANGTP –
interacts with RANGAP1 (Arnaoutov et al., 2005; Wu et al., 2013).
CRM1 can also bind RANBP2 in a zinc-finger domain outside the
importin-β-interacting FG-rich regions (Singh et al., 1999). Based
on these data, the RANBP2-RANGAP1 complex can ‘switch
partners’ via specific contacts with nuclear transport receptors:
importin-β with RANBP2, CRM1 with RANGAP1 and possibly
with a specific RANBP2 region. The switch does not disrupt the
integrity within the RRSU complex itself. The ‘preferred’ RRSU
partner in mitotic stages may simply reflect its physical proximity to
transport vectors. Importin-β associates with mitotic MTs and poles
via dynein (Ciciarello et al., 2004). CRM1 comprises fractions at
centrosomes, MTs, and a fraction anchored to KTs via the NPC
subcomplex NUP107-160 (Zuccolo et al., 2007). The RRSU may
interact with one or the other transport receptor depending on its
distance from them. Phosphorylation may further modulate local
interactions. Indeed, importin-β interactions are influenced by the
phosphorylation state of partners (Nardozzi et al., 2010). In
addition, CDK1–cyclin-B1 activity is involved in mitotic
phosphorylation of CRM1, and phosphorylated CRM1 shows
higher affinity for RANGAP1 compared with non-phosphorylatable
forms (Wu et al., 2013).
We also find that importin-β–RANBP2 PLA products form in
cells lackingMTs, but their distribution is spread. Similarly, the lack
of MT integrity did not affect RANBP2-CRM1 PLA formation, but
prevented their localisation to KTs; thus MTs are an integral part of
the RANBP2 ‘switch partners’ model during mitosis.
We have generated HeLa cell lines to induce overexpression of
either importin-β, or CRM1, in a controlled manner. High levels of
Fig. 8. Model for RANBP2-RANGAP1 recruitment to KTs. (A) Schematic representation of the spatial and temporal variations of RANBP2–SUMO-RANGAP1
(RRSU) interactions with transport factors during mitosis. In a physiological mitosis, RRSU recruitment to MT-attached KTs with CRM1 modulates local cycles of
protein SUMOylation and of nucleotide turnover on RAN. (B) In CRM1-induced cells, RANBP2 recruitment at KTs is anticipated in prometaphase. (C) In importin-
β-induced cells, RANBP2–importin-β PLA products are retained at MTs, while RANBP2-CRM1 decrease at KTs in metaphase. The altered timing (B), or
impairment (C), of RANBP2 localisation at KTs affects in turn the accumulation of SUMO-TOP2A at centromeres and the stability of K-fibres.
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overexpression of either receptor prevents mitotic entry altogether
(Ciciarello et al., 2004; Roscioli et al., 2012), whereas mild
overexpression of importin-β or CRM1, such as actually assessed in
cancer samples (van der Watt et al., 2009), does not prevent mitosis
and induces genetic instability during abnormal cell divisions. In
our cell lines, induction of moderate importin-β overexpression
retained RANBP2–importin-β PLA products along the spindle MTs
and prevented their decrease in metaphase, unlike in physiological
mitosis. Concomitant with this, the accumulation of CRM1-
RANBP2 PLA products at metaphase KTs was impaired.
Importantly, these cells failed to accumulate SUMO-TOP2A at
centromeres, a feature that has been associated with the origin of
aneuploidy. SUMO has been found to regulate both the centromere
decatenation function of TOP2A (Dawlaty et al., 2008) and its
interaction with haspin (Yoshida et al., 2016), which in turn acts in a
regulatory cross-talk with the Aurora B kinase. The defective
accumulation of SUMO-TOP2A at centromeres, associated with
RANBP2 retention at MTs, might underlie at least some of the
segregation defects recorded in importin-β-overexpression cells.
Furthermore, associated with defective RANBP2 interaction with
CRM1 at KTs, these cells also display decreased stability of mitotic
MTs revealed by impaired K-fibre resistance to cold-induced
depolymerisation.
Conversely, CRM1-overexpressing cells prematurely recruited
RANBP2 to prometaphase KTs. That was associated with mis-
segregation and generation of multinucleated cells. CRM1
overexpression therefore overrides the control mechanism that
normally retains RANBP2–SUMO-RANGAP1 at prometaphase
MTs and enables their delivery to KTs only after biorientation. This
suggests that, under these conditions, RANBP2 is transferred to KTs
at a stage at which MT attachments are not yet fully ‘mature’. These
attachments may be stabilised prematurely: indeed, cold assays
revealed hyperstable K-fibres associated with precocious RANBP2
localisation at KTs. Interestingly, we observed in parallel the
premature accumulation of SUMO-TOP2A at centromeres, which
may cause deregulated sister chromatid decatenation before
chromosomes are fully bioriented.
In conclusion, a model is beginning to emerge from the present
data (Fig. 8), whereby the mitotic localisation of RANBP2–SUMO-
RANGAP1 depends on the antagonistic actions of importin-β and
CRM1. In turn, this affects functional features of centromeres and
KTs. In this study, we have characterised SUMO-conjugated
TOP2A and K-fibre stability as two paradigmatic targets of properly
localised RANBP2 activity. It is reasonable to expect that other
processes that depend on protein SUMOylation may be similarly
altered under elevated levels of importin-β or CRM1.
Of note, several cancer types overexpress these karyopherins
(Rensen et al., 2008; van der Watt et al., 2009) and inhibitors of
nuclear transport processes are being developed with therapeutic
purposes (Stelma et al., 2016; Mahipal and Malafa, 2016). The
present data suggest that the relative abundance of importin-β and
CRM1 is crucial to KT functions that depend on the RRSU
complex.
MATERIALS AND METHODS
Cell culture, synchronisation and treatments
Human HeLa cells (American Tissue Culture Collection, CCL-2) were
grown in DMEM supplemented with 10% fetal bovine serum, 2%
L-glutamine, 2.5% HEPES and 2% penicillin-streptomycin at 37°C in 5%
CO2. Where indicated, cells were synchronised in 2 mM thymidine
for 20–24 h to arrest the cell cycle at the G1-S transition, then released
in medium containing 30 μM deoxycytidine. Cells were treated with
400 ng/ml NOC (Sigma-Aldrich) 10 h after thymidine release and harvested
4 h later. LMB (Enzo Life Sciences) was used at 20 nM in asynchronous
cultures for 2 h.
Generation of stable cell lines for importin-β and CRM1
Inducible expression vectors for importin-β-EGFP and CRM1-EGFP were
derived from the enhanced piggyBac (ePiggyBac) vector, carrying a
tetracycline-responsive promoter element followed by a multicloning site.
To generate epB-Bsd-TT-importin-β-EGFP, the sequence encoding
importin-β–EGFP (Ciciarello et al., 2004) was PCR amplified using
oligonucleotides pEGFP-N1_Fw_ClaI (GGCATCGATAGCGCTACCGG-
ACTC) and pEGFP-N1_Rv (ACCTCTACAAATGTGGTATGGC). The
PCR fragment was then digested and cloned between the ClaI and NotI sites
in the epB-Bsd-TT plasmid, in which the puromycin resistance gene in the
original epB-Puro-TT (Rosa et al., 2014) was replaced with a blasticidin
resistance gene. The epB-Bsd-TT-CRM1-EGFP vector was generated by
subcloning the CRM1-EGFP sequence (Roscioli et al., 2012) between the
BamHI and NotI sites of epB-Bsd-TT. HeLa cells were co-trasfected with
vector and hypb7 (encoding the transposase gene) using Lipofectamine
(Invitrogen). Twenty-four hours after transfection, the mediumwas replaced
with Tet-free DMEM supplemented with 3 μg/ml blasticidine-S
hydrochloride (Sigma). Blasticidine-S-resistant foci were expanded and
tested for expression after administration of 1 μg/ml doxycyline hyclate
(dox, Santa Cruz Biotechnology).
RNA interference
RNA oligonucleotides were: RANBP2, 5′-GGACAGUGGGAUUGUAG-
UGTT-3′ (Ambion); and GL2 (luciferase gene), 5′-CGUACGCGGAAU-
ACUUCGATT-3′ (Ambion). For CRM1 a pool of three siRNAs was used
(sc-35116, Santa Cruz Biotechnology). siRNA duplexes were diluted in
serum-free OptiMem and transfected using Oligofectamine (Invitrogen), at
150 nM (RANBP2) and 20 nM (CRM1 and GL2) final concentrations.
Immunofluorescence
Cells grown on polylysine-coated coverslips were fixed using 3.7%
paraformaldehyde in 30 mM sucrose, permeabilised in 0.1% Triton X-100
and incubated with antibodies. Primary antibodies are listed in Table S1.
Secondary antibodies were conjugated to fluorescein isothiocyanate (FITC,
green), Alexa 647 (far red), Cy3 (red) or 7-amino-4-methylcoumarin-3-
acetic acid (AMCA, blue) (Jackson Immunoresearch Laboratories), or Texas
Red (red, Vector Laboratories). DNA was stained with 0.1 µg/ml 4,6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich). Coverslips were
mounted in Vectashield (Vector Laboratories).
Proximity ligation assay (PLA)
The PLA method is based on recognition of the proteins of interest by
primary antibodies, followed by secondary antibodies conjugated with
oligonucleotide tails (called PLUS and MINUS). Connector
oligonucleotides complementary to the secondary antibody-conjugated
oligonucleotides are then added: when proteins are in close proximity
(<30 nm), the connector oligonucleotides can pair with the PLUS and
MINUS tails in a ligation step. This is followed by a rolling circle DNA
amplification, visualised by a complementary fluorescent probe.
Intramolecular PLA uses the same principle but uses primary antibodies
directed against different regions of the same protein or against a protein and
a candidate post-translational modification (here, TOP2A protein and
SUMO-2/3 peptides). Duolink PLA kits were used following the Olink
Bioscience protocol. Routinely, cells were blocked and incubated with
primary antibody as for IF; anti-mouse MINUS and anti-rabbit PLUS PLA
probes were then added and incubated in a pre-heated humidity chamber
(60 min, 37°C). Subsequent hybridisation, ligation and detection steps were
performed using the Duolink Detection kit according to the manufacturer’s
protocol. Primary antibodies are listed in Table S1.
MT depolymerisation assays
Uninduced (controls) or dox-induced (importin-β, CRM1) cultures were
placed on ice for 20 or 35 min. At the end of incubation they were washed in
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PTEMF buffer (20 mM Pipes, 10 mM EGTA, 1 mM MgCl2) to preserve
resistant MTs, fixed (3.7% PFA, 0.2% Triton X-100 in PTEMF), then
processed for IF as described above.
Microscopy
Fixed samples were analysed under a Nikon Eclipse 90i microscope
equipped with a Qicam Fast 1394 CCD camera (Qimaging). Single-cell
images were taken using an immersion oil 100× objective (NA 1.3) and
entire fields under a 40× objective (NA 0.75). Images were acquired using
NIS-Elements AR 3.2 and 4.0 software (Nikon); three-dimensional
deconvolution of 0.3–0.4 μm z-serial optical sections was performed
using the ‘AutoQuant’ deconvolution module of NIS-Element AR 3.2/4.0.
Creation of image projections was performed using the Maximum Intensity
Projection (MIP, for quantitative analyses), and Extended Depth of Focus
(EDF) functions of NIS-Element AR 3.2/4.0. IF signals were quantitatively
analysed using NIS-Element AR 3.2/4.0 (nd2 file format); external
background correction was applied and the sum intensity of signals on
indicated selected areas was measured. PLA spots were counted on images
acquired in three dimensions. In the manual count mode, PLA spots were
counted in each individual plane. In the automatic mode, images were
processed using the MIP method (therefore losing quantitative information
for separate planes), activating the ‘spot detection’ and ‘count objects’ tools
of NIS-Element AR 3.2/4.0. All figures shown in this work represent MIP
images unless specified otherwise. Images were processed with Adobe
Photoshop CS 8.0.
Time-lapse imaging
Cells were seeded in µ-Slide (chambered coverslip) with 4 or 8 wells
(80426/80821, IbiTreat; Ibidi) in Phenol Red-free DMEM supplemented as
above. During recording, cell cultures were kept at 37°C in a temperature-
and CO2-controlled microscope stage incubator (Okolab). Cultures were
recorded under an automated inverted microscope (Ti Eclipse; Nikon)
equipped with a DS-Qi1MC camera, an Intensilight C-HGFIE lamp, and
NIS-Elements 3.1 software (all from Nikon). Phase-contrast (60×, 0.7 NA)
objective was used. Cells were recorded for 6–24 h; phase-contrast images
were taken every 15 min and GFP fluorescence images every 60 min.
Western immunoblotting
HeLa cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 8, 150 mM
NaCl, 1% NP40, 1 mM EGTA, 1 mM EDTA, 0.1% SDS, 0.25% sodium
deoxycholate) supplemented with protease (05892791001, Roche) and
phosphatase (PhoSTOP, 04906837001, Roche) inhibitors. Proteins (40 μg
per lane)were separated throughSDS-PAGEand transferred to nitrocellulose
filters (Protran BA83, Whatman) in a semi-dry system (Bio-Rad). Blocking
and antibody incubations were in TBS (10 mM Tris-HCl, pH 7.4, 150 mM
NaCl) containing 0.1% Tween 20 and 5% low-fat milk. Primary and
secondary antibodies were incubated for 1 h at room temperature. Primary
antibodies are listed in Table S1. HRP-conjugated secondary antibodies
(Santa Cruz Biotechnology) were revealed using the ECL detection system
(GE Healthcare) on Hyperfilm-ECL films (GE Healthcare).
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(2016). Structural biology and regulation of protein import into the nucleus. J. Mol.
Biol. 428, 2060-2090.
Ciciarello, M., Mangiacasale, R., Thibier, C., Guarguaglini, G., Marchetti, E., Di
Fiore, B. and Lavia, P. (2004). Importin β is transported to spindle poles during
mitosis and regulates Ran-dependent spindle assembly factors in mammalian
cells. J. Cell Sci. 117, 6511-6522.
Ciciarello, M., Mangiacasale, R. and Lavia, P. (2007). Spatial control of mitosis by
the GTPase Ran. Cell. Mol. Life Sci. 64, 1891-1914.
Clarke, P. R. and Zhang, C. (2008). Spatial and temporal coordination of mitosis by
Ran GTPase. Nat. Rev. Mol. Cell Biol. 9, 464-477.
Cuben ̃as-Potts, C., Goeres, J. D. and Matunis, M. J. (2013). SENP1 and SENP2
affect spatial and temporal control of sumoylation in mitosis. Mol. Biol. Cell 24,
3483-3495.
Cuben ̃as-Potts, C., Srikumar, T., Lee, C., Osula, O., Subramonian, D., Zhang,
X.-D., Cotter, R. J., Raught, B. and Matunis, M. J. (2015). Identification of
SUMO-2/3 modified proteins associated with mitotic chromosomes. Proteomics
15, 763-772.
Dasso, M. (2006). Ran at kinetochores. Biochem. Soc. Trans. 34, 711-715.
Dawlaty, M. M., Malureanu, L., Jeganathan, K. B., Kao, E., Sustmann, C., Tahk,
S., Shuai, K., Grosschedl, R. and van Deursen, J. M. (2008). Resolution of
sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase
IIalpha. Cell 133, 103-115.
Eifler, K. and Vertegaal, A. C. (2015). SUMOylation-mediated regulation of cell
cycle progression and cancer. Trends Biochem. Sci. 40, 779-793.
Flotho, A. andWerner, A. (2012). The RanBP2/RanGAP1*SUMO1/Ubc9 complex:
a multisubunit E3 ligase at the intersection of sumoylation and the Ran GTPase
cycle. Nucleus 3, 429-432.
Forbes, D. J., Travesa, A., Nord, M. S. and Bernis, C. (2015). Nuclear transport
factors: global regulation of mitosis. Curr. Opin. Cell Biol. 35, 78-90.
Forgues, M., Difilippantonio, M. J., Linke, S. P., Ried, T., Nagashima, K., Feden,
J., Valerie, K., Fukasawa, K. and Wang, X. W. (2003). Involvement of Crm1 in
hepatitis B virus X protein-induced aberrant centriole replication and abnormal
mitotic spindles. Mol. Cell. Biol. 23, 5282-5292.
Hashizume, C., Kobayashi, A. and Wong, R. W. (2013). Down-modulation of
nucleoporin RanBP2/Nup358 impaired chromosomal alignment and induced
mitotic catastrophe. Cell Death Dis. 4, e854.
Joseph, J., Tan, S.-H., Karpova, T. S., McNally, J. G. and Dasso, M. (2002).
SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles. J. Cell Biol. 156,
595-602.
Joseph, J., Liu, S.-T., Jablonski, S. A., Yen, T. J. and Dasso, M. (2004). The
RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions
in vivo. Curr. Biol. 14, 611-617.
Kalab, P. and Heald, R. (2008). The RanGTP gradient – a GPS for the mitotic
spindle. J. Cell Sci. 121, 1577-1586.
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